Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001056568-05-000024
Filing Date
2005-02-14
Accepted
2005-02-14 15:43:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 NEOPHARM INC neol13gamd4.txt SC 13G/A 17581
  Complete submission text file 0001056568-05-000024.txt   19660
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Subject) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
Type: SC 13G/A | Act: 34 | File No.: 005-49245 | Film No.: 05609590
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 114 W 47TH STREET SUITE 1926 NEW YORK NY 10036
Business Address 114 W 47TH STREET SUITE 1926 NEW YORK NY 10036 2129444726
KERN CAPITAL MANAGEMENT LLC (Filed by) CIK: 0001056568 (see all company filings)

EIN.: 133958232 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A